Market research
AMRUTANJAN.NSE Amrutanjan Health Care Limited
NSE INR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 14B
- P/E ratio
- 26.27
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 0.38
Profile
Company facts
- Exchange
- NSE
- Currency
- INR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- INE098F01031
- Market cap
- 14B
- P/E ratio
- 26.27
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 0.38
About
About Amrutanjan Health Care Limited
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products in India and internationally. It operates through OTC Products, Beverages, Women's Hygiene, and Others segments. The company provides pain management products comprising pain balms and roll-ons, back pain roll-ons, stick-on patch, and joint muscle sprays; dental pain gel; and decorn corn caps; hand sanitizer under the NOGerms brand name; and fruit and rehydration juice drinks under the Fruitnik brand name. The company also offers congestion management products that consists of cold rubs, cough syrups, nasal inhalers, and swas mints, as well as provides sanitary napkins for women. In addition, it operates a pain management center. The company was formerly known as Amrutanjan Limited and changed its name to Amrutanjan Health Care Limited in 2007. Amrutanjan Health Care Limited was founded in 1893 and is based in Chennai, India.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the AMRUTANJAN.NSE discussion.
5 years, 5 months ago
Amrutanjan Health Care Limited is currently in a long term uptrend where the price is trading 26.2% above its 200 day moving average.
From a valuation standpoint, the stock is 21.1% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 5.8.
Amrutanjan Health Care Limited's total revenue rose by 21.0% to $1B since the same quarter in the previous year.
Its net income has increased by 121.1% to $210M since the same quarter in the previous year.
Finally, its free cash flow grew by 696.5% to $655M since the same quarter in the previous year.
Based on the above factors, Amrutanjan Health Care Limited gets an overall score of 4/5.